Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

This early-phase trial tested a new drug called HDM1005 in 40 overweight or obese adults. Participants received either the drug or a placebo as a shot under the skin. The main goal was to check safety and how the body processes the drug, not yet to prove it works for weight loss.

This early-stage study tested a single dose of an investigational drug called HDM1005 in 65 healthy adults who were overweight or had obesity. The main goal was to check if the injection is safe and how the body processes it. Researchers also looked at changes in weight and other…

This phase 3 trial tested a once-daily cream called roflumilast (0.15%) in 354 people aged 6 and older with mild to moderate atopic dermatitis (eczema). Participants applied the cream or a placebo for 4 weeks. The main goal was to see if the cream could make skin clear or almost …